Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


dEsparbes Eric Create: Alert

All | News | Filings
Date FiledTypeDescription
08/17/2023 4 dEsparbes Eric (CFO) has filed a Form 4 on BIORA THERAPEUTICS, INC.
Txns: Paid exercise price by delivering 40,022 shares @ $3.14, valued at $125.7k
Granted 219,650 shares @ $0
05/17/2023 4 dEsparbes Eric (CFO) has filed a Form 4 on BIORA THERAPEUTICS, INC.
Txns: Paid exercise price by delivering 2,807 shares @ $3.35, valued at $9.4k
03/17/2023 4 dEsparbes Eric (CFO) has filed a Form 4 on BIORA THERAPEUTICS, INC.
Txns: Granted 62,225 shares @ $0
Granted 22,692 shares @ $0
Paid exercise price by delivering 11,216 shares @ $2.56, valued at $28.7k
01/05/2023 4 dEsparbes Eric (CFO) has filed a Form 4 on BIORA THERAPEUTICS, INC.
Txns: Disposed/sold 95 shares @ $0
11/16/2022 4 dEsparbes Eric (CFO) has filed a Form 4 on BIORA THERAPEUTICS, INC.
Txns: Paid exercise price by delivering 5,194 shares @ $0.27, valued at $1.4k
08/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/19/2022 4 dEsparbes Eric (CFO) has filed a Form 4 on PROGENITY, INC.
Txns: Granted 231,693 shares @ $0
Granted 375,032 options to buy @ $1, valued at $375k
02/17/2022 4 dEsparbes Eric (CFO) has filed a Form 4 on PROGENITY, INC.
Txns: Paid exercise price by delivering 4,919 shares @ $1.9, valued at $9.3k
08/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/19/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/17/2021 4 dEsparbes Eric (CFO) has filed a Form 4 on PROGENITY, INC.
Txns: Granted 67,953 options to buy @ $4.73, valued at $321.4k
03/08/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/22/2020 4 dEsparbes Eric (CFO) has filed a Form 4 on PROGENITY, INC.
Txns: Paid exercise price by delivering 1,228 shares @ $6.32, valued at $7.8k
08/18/2020 4 dEsparbes Eric (CFO) has filed a Form 4 on PROGENITY, INC.
Txns: Granted 36,243 shares @ $0
Granted 73,863 options to buy @ $7.71, valued at $569.5k
Granted 28,406 options to buy @ $9.88, valued at $280.7k
06/18/2020 3 dEsparbes Eric (CFO) has filed a Form 3 on PROGENITY, INC.
05/22/2018 4 dEsparbes Eric (SVP and CFO) has filed a Form 4 on Innoviva, Inc.
Txns: Paid exercise price by delivering 7,901 shares @ $14.59, valued at $115.3k
Sold 5,808 shares @ $14.3979, valued at $83.6k
03/06/2018 4 dEsparbes Eric (Interim PEO, SVP and CFO) has filed a Form 4 on Innoviva, Inc.
Txns: Granted 93,056 shares @ $0
02/22/2018 4 dEsparbes Eric (Interim PEO, SVP and CFO) has filed a Form 4 on Innoviva, Inc.
Txns: Paid exercise price by delivering 24,876 shares @ $16.44, valued at $409k
Sold 5,378 shares @ $16.5164, valued at $88.8k
11/22/2017 4 dEsparbes Eric (SVP and CFO) has filed a Form 4 on Innoviva, Inc.
Txns: Paid exercise price by delivering 6,141 shares @ $13.17, valued at $80.9k
Sold 1,825 shares @ $13.04, valued at $23.8k
Sold 13,460 shares @ $13.3114, valued at $179.2k
08/22/2017 4 dEsparbes Eric (SVP and CFO) has filed a Form 4 on Innoviva, Inc.
Txns: Paid exercise price by delivering 5,770 shares @ $12.28, valued at $70.9k
Sold 1,825 shares @ $12.2, valued at $22.3k
05/23/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/22/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
01/19/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
11/22/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
08/23/2016 4 dEsparbes Eric (SVP and CFO) has filed a Form 4 on Innoviva, Inc.
Txns: Paid exercise price by delivering 2,845 shares @ $11.79, valued at $33.5k
Sold 3,700 shares @ $11.77, valued at $43.5k
05/20/2016 4 dEsparbes Eric (SVP and CFO) has filed a Form 4 on Innoviva, Inc.
Txns: Paid exercise price by delivering 2,818 shares @ $11.09, valued at $31.3k

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy